Aclarion, inc. announces delayed 10-q filing

Broomfield, co, may 23, 2023 (globe newswire) -- via newmediawire – aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it will not file its quarterly report for the quarter ended march 31, 2023 within the filing deadline established by the securities and exchange commission and will be a late filer with respect to such report.
ACON Ratings Summary
ACON Quant Ranking